Sirion biotech gmbh:1315629 [19-003467]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90019P00190
- Awardee
-
Revvity Gene Delivery GMBH UEI MSN6VLEJCHC5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,967
Award facts
- Contract value 100% obligated
- $21,966.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1 | |
| Funding Only Action | $1,460 | |
| Funding Only Action | $2,507 | |
| Original award | $18,000 |
About this award
The NIH Clinical Center awarded a purchase order to Sirion Biotech GMBH valued at $21,966.56 on January 28, 2019. Performance is located in Germany with an ultimate completion date of February 19, 2019. The order is for LENTIBOOST formulated, GMP-grade lentiviral viral vector products to support gene therapy research. Pricing is firm fixed price with no small business set-aside applied.
Quick answers
Who was awarded contract 75N90019P00190?
75N90019P00190 was awarded to Revvity Gene Delivery GMBH by NIH Clinical Center (National Institutes of Health) on January 28, 2019.
How much is contract 75N90019P00190 worth?
The government has obligated $21,967 on 75N90019P00190.
Was contract 75N90019P00190 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award